Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 459-330-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11/Jan/18 - 27/Mar/18
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether
- EC Number:
- 609-858-6
- Cas Number:
- 406-78-0
- Molecular formula:
- C4H3F7O
- IUPAC Name:
- 1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether
- Test material form:
- liquid
- Details on test material:
- Batch number: 51806180
Expiry: 29 November 2018
Purity: 99.99% (Area %)
Constituent 1
- Specific details on test material used for the study:
- Name: 1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether
Other name: HFE-347-pc-f (Product name: ASAHIKLIN AE-3000)
CAS number: 406-78-0
Fomula: CF3CH2OCF2CF2H
Molecular weight: 200.07
Purity: 99.993%
Lot number: 51712010
The test substance was put into an airtight container and stored at room temperature in the test substance storage room (permissible range from 10
Test animals
- Species:
- mouse
- Details on species / strain selection:
- Crl:CD1(ICR), SPF
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- 27 male mice were purchased for the study, which were 6 weeks old when purchased. At administration, the mice were 7 weeks old and were within ±20% of the mean body weight (29.7-36.6g). Animals were observed at receipt and healthy mice were quarantined and acclimatised for 6 days. The clinical signs were observed daily during the quarantine and acclimatisation periods. Body weights were measured at animal receipt and completion of quarantine. After quarantine and acclimatisation, healthy mice were allocated by a body weight-stratified random sampling method on the day before administration. Mice were allocated to 5 groups at 5 animals per group for administration. Remaining animals after allocation (2) were excluded from the study.
At animal receipt, the animal number was assigned arbitrarily and 5 or less animals per cage were accommodated in order of the numerical order. Four animals of the smaller number in each cage were given the marking from 1 to 4 on their tails, using oil-based ink. The fifth animal was not marked. After the allocation, a new animal number was assigned. Two to three animals were housed per cage (1 to 2 cages per dose). The animals were given the marking from 1 to 5 on their back using water-based ink. Different colours were used for each dose.
The temperature and relative humidity used for the study were 22.9-23.9°C and 48.7-60% respectively. The air change rate was 10-15 times per hour and there was a 12h on/ 12h off light cycle. The mice were kept in polycarbonate cages with a flat bottom (210W x 320D x 130H mm), at a rearing density of 5 animals/ less per cage before the allocation and 3 animals/ less per cage after the allocation. Cages, cage lids, bedding, enrichment and water bottles were changed at completion of quarantine. Cages and bedding were changed when animals were transferred for a dissection. For their diet, animals were given free access to diets of autoclaved MF pellets and the water from Hita City water supply was chlorinated at about 3-5ppm, by adding sodium hypochlorite (Pure lox). The animals were given free access to the water. Contaminants in the drinking water were analysed twice per year and before the animal receipt, it was confirmed that the latest analytical data met the criteria of the ordinance.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Olive oil
- Details on exposure:
- Test substance group and negative control group: Administration was repeated twice within a 24h interval by the oral gavage, which is generally used for the micronucleus test. The test substance solutions were dispensed using a 1mL disposable syringe with a disposable stomach probe. Administration was carried out at 10mL/kg based on the body weight on the administration day
- Duration of treatment / exposure:
- 24 hours
- Frequency of treatment:
- Twice (24 hour interval)
- Post exposure period:
- 1 hour
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day
- Dose / conc.:
- 1 000 mg/kg bw/day
- Dose / conc.:
- 2 000 mg/kg bw/day
- No. of animals per sex per dose:
- 5 males
- Positive control(s):
- Mitomycin C (MMC) was selected as the positive control substance and was stored in the test substance room at room temperature.
Distilled water for injection was added to a vial containing 2 mg of MMC. MMC was dissolved to prepare 10mL of 0.2mg/mL MMC solution. The solution was used within 4 hours after preparation. On the second administration day of the test substance, an intraperitoneal administration of the positive control substance was carried out one time at 10mL/kg, based on the body weight on the administration day, using a 1mL disposable syringe with a disposable needle.
Examinations
- Tissues and cell types examined:
- Bone marrow cells from the femur
- Details of tissue and slide preparation:
- The animals were euthanised by a cervical dislocation. The femur was removed, and bone marrow cells were collected with approx. 0.8mL of heat-inactivated foetal bovine serum into a centrifuge tube and the tube was centrifuged at 1000rpm for 5 minutes. A small amount of the cell suspension was smeared onto a glass slide. The smears were completely air-dried and fixed with methanol. Then, the specimens were stained with 3vol% Giemsa solution prepared with 1/15 mol/L phosphate buffer solution (pH 6.8) and treated with 0.004% w/v% citrate aqueous solution.
The specimens of the negative and positive control groups and 3 doses in the test substance group were observed. Slide numbers were allocated randomly to specimens to be observed. The specimens were observed microscopically (x1000) in a blinded manner. - Evaluation criteria:
- Frequency of micronuclei:
4000 polychromatic erythrocytes (PCE) per animal (2000 PCE per specimen) were observed and the frequency of micronucleated polychromatic erythrocytes (MNPCE) (MNPCE/PCE) was calculated.
Growth inhibition of bone marrow cells:
A total of 500 erythrocytes (TE) per animal (250 TE per specimen) were observed and the ration of PCE to TE (PCE/TE) was calculated.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Remarks:
- The means of the MNPCE/PCE in bone marrow cells in mice treated at each dose level were within the range of historical data for the controls.
- Toxicity:
- yes
- Remarks:
- Evidence of toxicity was seen in mice dosed with either 1000 or 2000 mg/kg.
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Remarks:
- Vehicle controls used as negative controls.
- Positive controls validity:
- valid
- Remarks on result:
- other: No remarks
- Additional information on results:
- Clinical signs: No animals died in any groups. In the test substance group, the toxicity symptom was observed at 1000 and 2000 mg/kg/day. No abnormalities were observed in the negative or positive control groups.
Body weight: No significant difference was noted in body weight when compared with the negative control group in all doses of the test substance, until the day after the second administration.
MNPCE/PCE and PCE/TE: The means of the MNPCE/PCE in the negative and positive control groups were 0.120% and 6.850% respectively. The means of the MNPCE/PCE at 500, 1000 and 2000mg/kg/day of the test substance group were 0.050%, 0.085% and 0.060% respectively. At the positive control groups, statistically significant differences were observed at the 1% level. At all doses in the test substance group, MNPCE/PCEs were within the range of the historical data of the negative control. The means of the PCE/TE of the negative and positive control groups were 50.0% and 45.4% respectively. The means of the PCE/TE at 500, 1000 and 2000 mg/kg/day of the test substance groups were 48.3%, 42,2% and 47.7% respectively.
Any other information on results incl. tables
The means of the MNPCE/ PCE in the negative and positive control groups were within the range of the historical data in the testing facility. The mean of MNPCE/ PCE in the positive control was showed a statistically significant increase at both sides of the 1% level. In the test substance group, the PCE/TE was 20% of more compared with that of the negative control group at all observation doses. Therefore, it was confirmed that the test was conducted appropriately.
The means of the MNPCE/ PCEs of the test substance group at all observation doses were within the range of the historical data of the negative control. Therefore, the results were judged to be negative.
In the PCE/TE, since no statistically significant differences were observed in any doses of the test substance group compared to the negative control group, the exposure of the test substance to bone marrow cells was not proved. In the micronucleus test, the toxicity symptom was observed at 1000 and 2000 mg/kg/day. Therefore, it was judged that the potential to induce the micronuclei was evaluated adequately by the results of this study.
Applicant's summary and conclusion
- Conclusions:
- It was concluded that HFE-347pc-f did not induce the micronuclei under the present test conditions
- Executive summary:
1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether was administered to 7-week old Crl:CD1(ICR) male mice twice, at a 24 hour interval by oral gavage, in order to investigate the ability of HFE-347pc-f to induce micronuclei. The LD50 of the test substance was 2000mg/kg/day or more in the result of the acute oral toxicity test in male and female rats, from the information provided by the sponsor. Therefore, in the micronucleus test, the highest dose selected was 2000mg/kg/day, with two lower doses of 1000 and 500mg/kg/day set based on a geometric ratio of 2. Since it was found that there was no difference of the LD50 between males and females, only male mice were used for the micronucleus test.
The vehicle, olive oil was administered at 10mL/kg twice, at a 24 -hour interval by oral gavage, as a negative control. Mitomycin C was administered intraperitoneally at 2mg/kg/day once as the positive control.
In the micronucleus test, no animals died at any dose until 24 hours after the second administration. Therefore, doses of observation of specimens were selected as 500, 1000 and 2000mg/kg/day. The frequencies of the micronucleated polychromatic erythrocytes to polychromatic erythrocytes (MNPCE/PCE) in bone marrow cells and the ratio of PCE to total erythrocytes (PCE/TE) were examined. The means of MNPCE/PCEs of the test substance group at all observation doses were within the range of the historical data of the negative control. Therefore, the results were judged to be negative.
In the PCE/TE, since no statistically significant differences were observed in any doses of the test substance group compared to the negative control group, the exposure of the test substance to bone marrow cells was not proved. In the micronucleus test, the toxicity symptom was observed at 1000 and 2000mg/kg/day. Therefore, it was judged that the potential to induce the micronuclei was evaluated adequately by the results of this study.
Consequently, it was concluded that 1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether did not induce the micronuclei in mice bone marrow cells under the present test conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.